Mumps outbreak investigation in Jaisalmer, Rajasthan, India, June-September 2016
- PMID: 30252936
- PMCID: PMC6409212
- DOI: 10.1002/jmv.25324
Mumps outbreak investigation in Jaisalmer, Rajasthan, India, June-September 2016
Abstract
Mumps, a vaccine-preventable disease, cause inflammation of salivary glands and may cause severe complications, such as encephalitis, meningitis, deafness, and orchitis/oophoritis. In India, mumps vaccine is not included in the universal immunization program and during 2009 to 2014, 72 outbreaks with greater than 1500 cases were reported. In August 2016, a suspected mumps outbreak was reported in Jaisalmer block, Rajasthan. We investigated to confirm the etiology, describe the epidemiology, and recommend prevention and control measures. We defined a case as swelling in the parotid region in a Jaisalmer block resident between 23 June 2016 and 10 September 2016. We searched for cases in health facilities and house-to-house in affected villages and hamlets. We tested blood samples of cases for mumps immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA). We found 162 cases (60% males) with a median age of 9.4 years (range: 7 month-38 years) and 65 (40%) were females. Symptoms included fever (70%) and bilateral swelling in neck (65%). None of them were vaccinated against mumps. Most (84%) cases were school-going children (3-16 years old). The overall attack rate was 2%. Village A, with two hamlets, had the highest attack rate (hamlet 1 = 13% and hamlet 2 = 12%). School A of village A, hamlet 1, which accommodated 200 children in two classrooms, had an attack rate of 55%. Of 18 blood samples from cases, 11 tested positive for mumps IgM ELISA. This was a confirmed mumps outbreak in Jaisalmer block that disproportionately affected school-going children. We recommended continued surveillance, 5-day absence from school, and vaccination.
Keywords: mumps; outbreak; surveillance; vaccination.
© 2018 Wiley Periodicals, Inc.
Conflict of interest statement
CONFLICTS OF INTEREST
The authors declare that they have no conflicts of interest.
Figures
References
-
- Heymann DL. Mumps. Control of Communicable Diseases Manual 19 ed. Washington, D.C: American Public Health Association; 2008: pp. 431–434.
-
- Mumps virus vaccines. Wkly Epidemiol Rec 2007;82(7):51–60. - PubMed
-
- WHO-recommended Standards For Surveillance Of Selected Vaccine-Preventable Diseases Geneva, Switzerland: World Health Organization; 2003.
-
- Hviid A, Rubin S, Mühlemann K. Mumps. The Lancet 2008; 371(9616):932–944. - PubMed
-
- Integrated Disease Surveillance Program (IDSP). National Centre for Disease Control, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India http://idsp.nic.in/idsp/IDSP/rcntobrk.pdf. Accessed January 10, 2017.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
